| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000233845.1 |
Gefitinib |
Esophageal cancer |
0.003064462 |
Resistant |
| ENSG00000233845.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042433677 |
Sensitive |
| ENSG00000233845.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.022079159 |
Sensitive |
